Distinct signalling mechanisms are involved in the dissimilar myocardial and coronary effects elicited by quercetin and myricetin, two red wine flavonols

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 5, 2011, Pages 362-371

  Angelone, T ^a   Pasqua, T ^a   Di Majo, D ^b   Quintieri, A M ^a   Filice, E ^a   Amodio, N ^c   Tota, B ^a   Giammanco, M ^b   Cerra, M C ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Myocardial contractility; Myricetin; Nitric oxide; Quercetin; Vasoreactivity

Indexed keywords

ANTIOXIDANT; FLAVONOID; MYRICETIN; OCTOXINOL; QUERCETIN;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; DRUG EFFECT; HEART; HEART MUSCLE; IN VITRO STUDY; MALE; METABOLISM; RAT; SIGNAL TRANSDUCTION; VASODILATATION; WINE; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; FLAVONOIDS; HEART; MALE; MYOCARDIUM; OCTOXYNOL; QUERCETIN; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; VASODILATION; WINE;

MAMMALIA; RATTUS;

EID: 79954629254     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.10.011     Document Type: Article

References (29)

1. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000, 130:2073-2085.
2. de Vries J.H., Janssen P.L., Hollman P.C., van Staveren W.A., Katan M.B. Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets. Cancer Lett 1997, 114:141-144.
3. Hertog M.G.L., Hollman P.C.H., Katan M.B. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in The Netherlands. J Agric Food Chem 1992, 40:2379-2383.
4. Formica J.V., Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 1995, 33:1061-1080.
5. Fusi F., Saponara S., Pessina F., Gorelli B., Sgaragli G. Effects of quercetin and rutin on vascular preparations: a comparison between mechanical and electrophysiological phenomena. Eur J Nutr 2003, 42:10-17.
6. Ajay M., Achike F.I., Mustafa A.M., Mustafa M.R. Direct effects of quercetin on impaired reactivity of spontaneously hypertensive rat aortae: comparative study with ascorbic acid. Clin Exp Pharmacol Physiol 2006, 33:345-350.
7. Machha A., Mustafa M.R. Chronic treatment with flavonoids prevents endothelial dysfunction in spontaneously hypertensive rat aorta. J Cardiovas Pharmacol 2005, 46:36-40.
8. Duarte J., Perez-Palencia R., Vargas F., Ocete M.A., Perez-Vizcaino F., Zarzuelo A., et al. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br J Pharmacol 2001, 133:117-124.
9. Ko C.H., Shen S.C., Lee T.J., Chen Y.C. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol Cancer Ther 2005, 4:281-290.
10. Ono K., Nakane H., Fukushima M., Chermann J.C., Barrè-Sinoussi F. Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur J Biochem 1990, 190:469-476.
11. Tzeng S.H., Ko W.C., Ko F.N., Teng C.M. Inhibition of plateled aggregation by some flavonoids. Thromb Res 1991, 64:91-100.
12. Robak J., Gryglewski R.J. Flavonoids are scavengers of superoxide anions. Biochem Pharmacol 1988, 37:837-841.
13. Mira L., Fernandez M.T., Santos M., Rocha R., Florêncio M.H., Jennings K.R. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res 2002, 36:1199-1208.
14. Tiwari R., Mohan M., Kasture S., Maxia A., Ballero M. Cardioprotective potential of Myricetin in isoproterenol-induced myocardial infarction in wistar rats. Phytother Res 2009, [Epub ahead of print].
15. Angelone T., Quintieri A.M., Brar B.K., Limchaiyawat P.T., Tota B., Mahata S.K., et al. The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism. Endocrinology 2008, 149:4780-4793.
16. Kennedy R.H., Owings R., Shekhawat N., Joseph J. Acute negative inotropic effects of homocysteine are mediated via the endothelium. Am J Physiol Heart Circ Physiol 2004, 287:812-817.
17. Kook D., Wolf A.H., Yu A.L., Neubauer A.S., Priglinger S.G., Kampik A., et al. The protective effect of quercetin against oxidative stress in the human RPE in vitro. Invest Ophthalmol Vis Sci 2008, 49:1712-1720.
18. Laekeman G.M., Glaeys M., Rwangabo P.C., Herman A.G., Vlietinck A.J. Cardiovascular effects of 3-methylquercetin. Planta Med 1986, 52:433-437.
19. Itoigawa M., Takeya K., Ito C., Furukawa H. Structure-activity relationship of cardiotonic flavonoids in guinea-pig papillary muscle. J Ethnopharmacol 1999, 65:267-272.
20. Roghani M., Baluchnejadmojarad T., Vaez-Mahdavi M.R., Roghani-Dehkordi F. Mechanisms underlying quercetin-induced vasorelaxation in aorta of subchronic diabetic rats: an in vitro study. Vascul Pharmacol 2004, 42:31-35.
21. Zhang Y.H., Park Y.S., Kim T.J., Fang L.H., Ahn H.Y., Hong J.T., et al. Endothelium-dependent vasorelaxant and antiproliferative effects of apigenin. Gen Pharmacol 2000, 35:341-347.
22. Xu Y.C., Leung S.W.S., Yeung D.K.Y., Hu L.H., Chen G.H., Che C.M., et al. Structure-activity relationships of flavonoids for vascular relaxation in porcine coronary artery. Phytochemistry 2007, 68:1179-1188.
23. Ajay M., Achike F.I., Mustafa A.M., Mustafa M.R. Effect of quercetin on altered vascular reactivity in aortas isolated from streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 2006, 73:1-7.
24. Bhansali B.B., Subhash V., Goyal R.K. Cardiac effects of quercetin on the isolated rabbit and frog heart preparations. Indian J Pharmacol 1987, 19:100-107.
25. Ko W.C., Shih C.M., Lai Y.H., Chen J.H., Huang H.L. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships. Biochem Pharmacol 2004, 68:2087-2094.
26. Shah A.M. Paracrine modulation of heart cell function by endothelial cells. Cardiovasc Res 1996, 31:847-867.
27. Westermann D., Riad A., Richter U., Jäger S., Savvatis K., Schuchardt M., et al. Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure. Basic Res Cardiol 2009, [Epub ahead of print].
28. Qin C.X., Chen X., Hughes R.A., Williams S.J., Woodman O.L. Understanding the cardioprotective effects of flavonols: discovery of relaxant flavonols without antioxidant activity. J Med Chem 2008, 51:1874-1884.
29. Lagrue-Lak-Hal A.H., Andriantsitohaina R. Red wine and cardiovascular risks. Arch Mal Coeur Vaiss 2006, 99:1230-1235.